GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuidelOrtho Corp (LTS:0A55) » Definitions » Gross-Profit-to-Asset %

QuidelOrtho (LTS:0A55) Gross-Profit-to-Asset % : 17.40% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is QuidelOrtho Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. QuidelOrtho's annualized Gross Profit for the quarter that ended in Mar. 2024 was $1,328 Mil. QuidelOrtho's average Total Assets over the quarter that ended in Mar. 2024 was $7,633 Mil. Therefore, QuidelOrtho's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 17.40%.


QuidelOrtho Gross-Profit-to-Asset % Historical Data

The historical data trend for QuidelOrtho's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QuidelOrtho Gross-Profit-to-Asset % Chart

QuidelOrtho Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.36 96.97 59.43 34.31 17.16

QuidelOrtho Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.34 13.68 17.23 17.84 17.40

Competitive Comparison of QuidelOrtho's Gross-Profit-to-Asset %

For the Medical Devices subindustry, QuidelOrtho's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QuidelOrtho's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QuidelOrtho's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where QuidelOrtho's Gross-Profit-to-Asset % falls into.



QuidelOrtho Gross-Profit-to-Asset % Calculation

QuidelOrtho's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=1494.4/( (8855.8+8563.1)/ 2 )
=1494.4/8709.45
=17.16 %

QuidelOrtho's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=1328.4/( (8563.1+6703.3)/ 2 )
=1328.4/7633.2
=17.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


QuidelOrtho Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of QuidelOrtho's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


QuidelOrtho (LTS:0A55) Business Description

Traded in Other Exchanges
Address
9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make better decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.

QuidelOrtho (LTS:0A55) Headlines

No Headlines